These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 23446514)

  • 1. Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(8):148-51. PubMed ID: 23446514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
    Tippett Barr BA; van Lettow M; van Oosterhout JJ; Landes M; Shiraishi RW; Amene E; Schouten E; Wadonda-Kabondo N; Gupta S; Auld AF; Kalua T; Jahn A
    Lancet HIV; 2018 Dec; 5(12):e688-e695. PubMed ID: 30467022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Program Implementation of Option B+ at a President's Emergency Plan for AIDS Relief-Supported HIV Clinic Improves Clinical Indicators But Not Retention in Care in Mbarara, Uganda.
    Miller K; Muyindike W; Matthews LT; Kanyesigye M; Siedner MJ
    AIDS Patient Care STDS; 2017 Aug; 31(8):335-341. PubMed ID: 28650703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
    van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
    J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.
    Ngarina M; Tarimo EA; Naburi H; Kilewo C; Mwanyika-Sando M; Chalamilla G; Biberfeld G; Ekstrom AM
    PLoS One; 2014; 9(1):e85310. PubMed ID: 24465532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.
    Haas AD; van Oosterhout JJ; Tenthani L; Jahn A; Zwahlen M; Msukwa MT; Davies MA; Tal K; Phiri N; Spoerri A; Chimbwandira F; Egger M; Keiser O
    J Int AIDS Soc; 2017 Sep; 20(1):21947. PubMed ID: 28884524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-facility linkage models and maternal and infant health outcomes in Malawi's PMTCT/ART program: A cohort study.
    Herce ME; Chagomerana MB; Zalla LC; Carbone NB; Chi BH; Eliya MT; Phiri S; Topp SM; Kim MH; Wroe EB; Chilangwa C; Chinkonde J; Mofolo IA; Hosseinipour MC; Edwards JK
    PLoS Med; 2021 Sep; 18(9):e1003780. PubMed ID: 34534213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A qualitative analysis of the barriers and facilitators to receiving care in a prevention of mother-to-child program in Nkhoma, Malawi.
    Iroezi ND; Mindry D; Kawale P; Chikowi G; Jansen PA; Hoffman RM
    Afr J Reprod Health; 2013 Dec; 17(4 Spec No):118-29. PubMed ID: 24689323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi.
    Cataldo F; Chiwaula L; Nkhata M; van Lettow M; Kasende F; Rosenberg NE; Tweya H; Sampathkumar V; Hosseinipour M; Schouten E; Kapito-Tembo A; Eliya M; Chimbwandira F; Phiri S;
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):517-522. PubMed ID: 28045712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
    Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S;
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operational issues and barriers to implementation of prevention of mother-to-child transmission of HIV (PMTCT) interventions in Sub-Saharan Africa.
    Aizire J; Fowler MG; Coovadia HM
    Curr HIV Res; 2013 Mar; 11(2):144-59. PubMed ID: 23432490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons Learned From Option B+ in the Evolution Toward "Test and Start" From Malawi, Cameroon, and the United Republic of Tanzania.
    Kalua T; Tippett Barr BA; van Oosterhout JJ; Mbori-Ngacha D; Schouten EJ; Gupta S; Sande A; Zomba G; Tweya H; Lungu E; Kajoka D; Tih P; Jahn A
    J Acquir Immune Defic Syndr; 2017 May; 75 Suppl 1(Suppl 1):S43-S50. PubMed ID: 28398996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of guidelines on prevention of mother-to-child transmission of HIV in rural Tanzania: time for change.
    Gamell A; Letang E; Jullu B; Mwaigomole G; Nyamtema A; Hatz C; Battegay M; Tanner M
    Swiss Med Wkly; 2013; 143():w13775. PubMed ID: 23519621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the impact of prevention of mother-to-child transmission of HIV in Malawi through immunization clinic-based surveillance.
    Sinunu MA; Schouten EJ; Wadonda-Kabondo N; Kajawo E; Eliya M; Moyo K; Chimbwandira F; Strunin L; Kellerman SE
    PLoS One; 2014; 9(6):e100741. PubMed ID: 24968298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and Cost Drivers of Providing Option B+ Services to Mother-Baby Pairs for PMTCT of HIV in Health Centre IV Facilities in Jinja District, Uganda.
    Mukose AD; Kebede S; Muhumuza C; Makumbi F; Komakech H; Bayiga E; Busobozi D; Musinguzi J; Kuznik A; Stegman P; Forsythe S; Kagaayi J
    Biomed Res Int; 2020; 2020():2875864. PubMed ID: 32550228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving toward test and start: learning from the experience of universal antiretroviral therapy programs for HIV-infected pregnant/ breastfeeding women.
    Forhan SE; Modi S; Houston JC; Broyles LN
    AIDS; 2017 Jun; 31(10):1489-1493. PubMed ID: 28574966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare worker experiences with Option B+ for prevention of mother-to-child HIV transmission in eSwatini: findings from a two-year follow-up study.
    DiCarlo AL; Gachuhi AB; Mthethwa-Hleta S; Shongwe S; Hlophe T; Peters ZJ; Zerbe A; Myer L; Langwenya N; Okello V; Sahabo R; Nuwagaba-Biribonwoha H; Abrams EJ
    BMC Health Serv Res; 2019 Apr; 19(1):210. PubMed ID: 30940149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
    Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
    Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.